295 related articles for article (PubMed ID: 32362051)
1. Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.
Grandolfo M; Romita P; Bonamonte D; Cazzato G; Hansel K; Stingeni L; Conforti C; Giuffrida R; Foti C
Dermatol Ther; 2020 Jul; 33(4):e13499. PubMed ID: 32362051
[No Abstract] [Full Text] [Related]
2. [Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?].
Defoort-Dhellemmes S
J Fr Ophtalmol; 2020 Jun; 43(6):548-549. PubMed ID: 32451138
[No Abstract] [Full Text] [Related]
3. COVID-19 and hydroxychloroquine: Is the wonder drug failing?
Paliani U; Cardona A
Eur J Intern Med; 2020 Aug; 78():1-3. PubMed ID: 32553587
[No Abstract] [Full Text] [Related]
4. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
5. Regulators split on antimalarials for COVID-19.
Jaffe S
Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
[No Abstract] [Full Text] [Related]
6. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
7. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
Schluger NW
Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
[TBL] [Abstract][Full Text] [Related]
8. Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
Oren O; Yang EH; Gluckman TJ; Michos ED; Blumenthal RS; Gersh BJ
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008688. PubMed ID: 32436730
[No Abstract] [Full Text] [Related]
9. A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).
Keshtkar-Jahromi M; Bavari S
Am J Trop Med Hyg; 2020 May; 102(5):932-933. PubMed ID: 32247318
[No Abstract] [Full Text] [Related]
10. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
Shah M; Sachdeva M; Dodiuk-Gad RP
Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251
[No Abstract] [Full Text] [Related]
11. Therapeutic conflict in patients with COVID-19 and glaucoma.
Millá Griñó E; Muniesa Royo MJ; Pazos López M
Med Clin (Barc); 2020 Aug; 155(4):182. PubMed ID: 32591182
[No Abstract] [Full Text] [Related]
12. Myasthenic Syndrome Caused by Hydroxychloroquine Used for COVID-19 Prophylaxis.
Koc G; Odabasi Z; Tan E
J Clin Neuromuscul Dis; 2020 Sep; 22(1):60-62. PubMed ID: 32833728
[No Abstract] [Full Text] [Related]
13. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
Halm MA
Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
[No Abstract] [Full Text] [Related]
14. Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?
Kamp TJ; Hamdan MH; January CT
J Am Heart Assoc; 2020 Jun; 9(12):e016887. PubMed ID: 32463308
[No Abstract] [Full Text] [Related]
15. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
Shih RD; Johnson HM; Maki DG; Hennekens CH
Am J Med; 2020 Sep; 133(9):1007-1008. PubMed ID: 32502485
[No Abstract] [Full Text] [Related]
16. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
Tomcsányi J; Tomcsányi K
Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363
[TBL] [Abstract][Full Text] [Related]
17. A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
Martinez Navarro W; Ly L; Segal MS; Shukla AM
Asia Pac J Ophthalmol (Phila); 2020; 9(4):374-375. PubMed ID: 32740071
[No Abstract] [Full Text] [Related]
18. What is the role of rheumatologists in the era of COVID-19?
Marotto D; Sarzi-Puttini P
Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
[No Abstract] [Full Text] [Related]
19. Race to find COVID-19 treatments accelerates.
Kupferschmidt K; Cohen J
Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
[No Abstract] [Full Text] [Related]
20. Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.
Monte Serrano J; Cruañes Monferrer J; García-García M; García-Gil MF
Med Clin (Barc); 2020 Sep; 155(5):231. PubMed ID: 32522372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
